Ignite Creation Date:
2025-12-24 @ 1:41 PM
Ignite Modification Date:
2026-01-03 @ 5:27 PM
Study NCT ID:
NCT03057795
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-05-07
First Post:
2017-02-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Nivolumab & Brentuximab Vedotin Consolidation After Autologous SCT in Patients With High-Risk Classical Hodgkin Lymphoma
Sponsor:
City of Hope Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-04-03
Start Date Type:
ACTUAL
Primary Completion Date:
2021-01-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-03-25
Completion Date Type:
ESTIMATED
First Submit Date:
2017-02-14
First Submit QC Date:
None
Study First Post Date:
2017-02-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-02-23
Results First Submit QC Date:
None
Results First Post Date:
2023-03-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-29
Last Update Post Date:
2025-05-07
Last Update Post Date Type:
ACTUAL